372 related articles for article (PubMed ID: 27821327)
1. Targeting nitrative stress for attenuating cisplatin-induced downregulation of cochlear LIM domain only 4 and ototoxicity.
Jamesdaniel S; Rathinam R; Neumann WL
Redox Biol; 2016 Dec; 10():257-265. PubMed ID: 27821327
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin-induced ototoxicity is mediated by nitroxidative modification of cochlear proteins characterized by nitration of Lmo4.
Jamesdaniel S; Coling D; Hinduja S; Ding D; Li J; Cassidy L; Seigel GM; Qu J; Salvi R
J Biol Chem; 2012 May; 287(22):18674-86. PubMed ID: 22493493
[TBL] [Abstract][Full Text] [Related]
3. Lmo4 Deficiency Enhances Susceptibility to Cisplatin-Induced Cochlear Apoptosis and Hearing Loss.
Rosati R; Shahab M; Ramkumar V; Jamesdaniel S
Mol Neurobiol; 2021 May; 58(5):2019-2029. PubMed ID: 33411315
[TBL] [Abstract][Full Text] [Related]
4. Downstream targets of Lmo4 are modulated by cisplatin in the inner ear of Wistar rats.
Jamesdaniel S
PLoS One; 2014; 9(12):e115263. PubMed ID: 25501662
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin-induced hair cell loss in zebrafish neuromasts is accompanied by protein nitration and Lmo4 degradation.
Shahab M; Rosati R; Meyer DN; Shields JN; Crofts E; Baker TR; Jamesdaniel S
Toxicol Appl Pharmacol; 2021 Jan; 410():115342. PubMed ID: 33245977
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin-induced apoptosis in auditory, renal, and neuronal cells is associated with nitration and downregulation of LMO4.
Rathinam R; Ghosh S; Neumann WL; Jamesdaniel S
Cell Death Discov; 2015; 1():15052-. PubMed ID: 26925255
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of protein nitration prevents cisplatin-induced inactivation of STAT3 and promotes anti-apoptotic signaling in organ of Corti cells.
Rosati R; Shahab M; Neumann WL; Jamesdaniel S
Exp Cell Res; 2019 Aug; 381(1):105-111. PubMed ID: 31078568
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-mediated knockout of Lim-domain only four retards organ of Corti cell growth.
Rathinam R; Rosati R; Jamesdaniel S
J Cell Biochem; 2018 Apr; 119(4):3545-3553. PubMed ID: 29143984
[TBL] [Abstract][Full Text] [Related]
9. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK.
Lee JS; Kang SU; Hwang HS; Pyun JH; Choung YH; Kim CH
Toxicol Lett; 2010 Dec; 199(3):308-16. PubMed ID: 20883750
[TBL] [Abstract][Full Text] [Related]
10. Nimodipine Treatment Protects Auditory Hair Cells from Cisplatin-Induced Cell Death Accompanied by Upregulation of LMO4.
Fritzsche S; Strauss C; Scheller C; Leisz S
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628594
[TBL] [Abstract][Full Text] [Related]
11. Ginkgolide B protects against cisplatin-induced ototoxicity: enhancement of Akt-Nrf2-HO-1 signaling and reduction of NADPH oxidase.
Ma W; Hu J; Cheng Y; Wang J; Zhang X; Xu M
Cancer Chemother Pharmacol; 2015 May; 75(5):949-59. PubMed ID: 25749575
[TBL] [Abstract][Full Text] [Related]
12. Lovastatin protects against cisplatin-induced hearing loss in mice.
Fernandez K; Spielbauer KK; Rusheen A; Wang L; Baker TG; Eyles S; Cunningham LL
Hear Res; 2020 Apr; 389():107905. PubMed ID: 32062294
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the protective effects of hesperetin against cisplatin-induced ototoxicity in a rat animal model.
Kara M; Türkön H; Karaca T; Güçlü O; Uysal S; Türkyılmaz M; Demirtaş S; Dereköy FS
Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():12-8. PubMed ID: 27240489
[TBL] [Abstract][Full Text] [Related]
14. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect.
Bielefeld EC; Tanaka C; Chen GD; Coling D; Li M; Henderson D; Fetoni AR
Anticancer Drugs; 2013 Jan; 24(1):43-51. PubMed ID: 22828384
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal Negative Regulation Between Lmx1a and Lmo4 Is Required for Inner Ear Formation.
Huang Y; Hill J; Yatteau A; Wong L; Jiang T; Petrovic J; Gan L; Dong L; Wu DK
J Neurosci; 2018 Jun; 38(23):5429-5440. PubMed ID: 29769265
[TBL] [Abstract][Full Text] [Related]
16. Sound preconditioning therapy inhibits ototoxic hearing loss in mice.
Roy S; Ryals MM; Van den Bruele AB; Fitzgerald TS; Cunningham LL
J Clin Invest; 2013 Nov; 123(11):4945-9. PubMed ID: 24216513
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity.
Borse V; Al Aameri RFH; Sheehan K; Sheth S; Kaur T; Mukherjea D; Tupal S; Lowy M; Ghosh S; Dhukhwa A; Bhatta P; Rybak LP; Ramkumar V
Cell Death Dis; 2017 Jul; 8(7):e2921. PubMed ID: 28703809
[TBL] [Abstract][Full Text] [Related]
18. Endoplasmic Reticulum Stress Is Involved in Cochlear Cell Apoptosis in a Cisplatin-Induced Ototoxicity Rat Model.
Zong S; Liu T; Wan F; Chen P; Luo P; Xiao H
Audiol Neurootol; 2017; 22(3):160-168. PubMed ID: 29049998
[TBL] [Abstract][Full Text] [Related]
19. Circadian vulnerability of cisplatin-induced ototoxicity in the cochlea.
Tserga E; Moreno-Paublete R; Sarlus H; Björn E; Guimaraes E; Göritz C; Cederroth CR; Canlon B
FASEB J; 2020 Oct; 34(10):13978-13992. PubMed ID: 32840016
[TBL] [Abstract][Full Text] [Related]
20. Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.
Kaur T; Borse V; Sheth S; Sheehan K; Ghosh S; Tupal S; Jajoo S; Mukherjea D; Rybak LP; Ramkumar V
J Neurosci; 2016 Apr; 36(14):3962-77. PubMed ID: 27053204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
